nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—UGT2B7—Epirubicin—testicular cancer	0.189	0.273	CbGbCtD
Etodolac—PTGS1—Ifosfamide—testicular cancer	0.135	0.195	CbGbCtD
Etodolac—PTGS2—Cisplatin—testicular cancer	0.0778	0.112	CbGbCtD
Etodolac—PTGS2—Etoposide—testicular cancer	0.0764	0.11	CbGbCtD
Etodolac—PTGS1—Etoposide—testicular cancer	0.0645	0.0932	CbGbCtD
Etodolac—CYP2C9—Ifosfamide—testicular cancer	0.0543	0.0785	CbGbCtD
Etodolac—SLC22A6—Methotrexate—testicular cancer	0.0374	0.054	CbGbCtD
Etodolac—ALB—Methotrexate—testicular cancer	0.0318	0.046	CbGbCtD
Etodolac—CYP2C9—Cisplatin—testicular cancer	0.0264	0.0382	CbGbCtD
Etodolac—Pneumonia—Epirubicin—testicular cancer	0.000249	0.000808	CcSEcCtD
Etodolac—Nausea—Bleomycin—testicular cancer	0.000247	0.000805	CcSEcCtD
Etodolac—Vomiting—Dactinomycin—testicular cancer	0.000247	0.000803	CcSEcCtD
Etodolac—Bronchitis—Doxorubicin—testicular cancer	0.000247	0.000802	CcSEcCtD
Etodolac—Agranulocytosis—Methotrexate—testicular cancer	0.000246	0.000802	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000245	0.000797	CcSEcCtD
Etodolac—Rash—Dactinomycin—testicular cancer	0.000245	0.000797	CcSEcCtD
Etodolac—Decreased appetite—Etoposide—testicular cancer	0.000244	0.000795	CcSEcCtD
Etodolac—Diarrhoea—Ifosfamide—testicular cancer	0.000244	0.000792	CcSEcCtD
Etodolac—Pancytopenia—Doxorubicin—testicular cancer	0.000244	0.000792	CcSEcCtD
Etodolac—Renal failure—Epirubicin—testicular cancer	0.000243	0.00079	CcSEcCtD
Etodolac—Body temperature increased—Cisplatin—testicular cancer	0.000243	0.000789	CcSEcCtD
Etodolac—Fatigue—Etoposide—testicular cancer	0.000242	0.000788	CcSEcCtD
Etodolac—Stomatitis—Epirubicin—testicular cancer	0.000241	0.000783	CcSEcCtD
Etodolac—Jaundice—Epirubicin—testicular cancer	0.000241	0.000783	CcSEcCtD
Etodolac—Pain—Etoposide—testicular cancer	0.00024	0.000782	CcSEcCtD
Etodolac—Constipation—Etoposide—testicular cancer	0.00024	0.000782	CcSEcCtD
Etodolac—Conjunctivitis—Epirubicin—testicular cancer	0.00024	0.000781	CcSEcCtD
Etodolac—Neutropenia—Doxorubicin—testicular cancer	0.00024	0.00078	CcSEcCtD
Etodolac—Dysuria—Doxorubicin—testicular cancer	0.00024	0.00078	CcSEcCtD
Etodolac—Haemoglobin—Methotrexate—testicular cancer	0.000238	0.000775	CcSEcCtD
Etodolac—Hepatitis—Methotrexate—testicular cancer	0.000237	0.000771	CcSEcCtD
Etodolac—Haemorrhage—Methotrexate—testicular cancer	0.000237	0.000771	CcSEcCtD
Etodolac—Sweating—Epirubicin—testicular cancer	0.000237	0.000771	CcSEcCtD
Etodolac—Pollakiuria—Doxorubicin—testicular cancer	0.000237	0.000771	CcSEcCtD
Etodolac—Haematuria—Epirubicin—testicular cancer	0.000236	0.000766	CcSEcCtD
Etodolac—Dizziness—Ifosfamide—testicular cancer	0.000235	0.000766	CcSEcCtD
Etodolac—Pharyngitis—Methotrexate—testicular cancer	0.000235	0.000765	CcSEcCtD
Etodolac—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000234	0.000761	CcSEcCtD
Etodolac—Sinusitis—Epirubicin—testicular cancer	0.000232	0.000754	CcSEcCtD
Etodolac—Feeling abnormal—Etoposide—testicular cancer	0.000232	0.000754	CcSEcCtD
Etodolac—Hyperglycaemia—Doxorubicin—testicular cancer	0.000231	0.000752	CcSEcCtD
Etodolac—Nausea—Dactinomycin—testicular cancer	0.000231	0.000751	CcSEcCtD
Etodolac—Agranulocytosis—Epirubicin—testicular cancer	0.000231	0.00075	CcSEcCtD
Etodolac—Pneumonia—Doxorubicin—testicular cancer	0.00023	0.000748	CcSEcCtD
Etodolac—Gastrointestinal pain—Etoposide—testicular cancer	0.00023	0.000748	CcSEcCtD
Etodolac—Visual impairment—Methotrexate—testicular cancer	0.000228	0.000743	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000227	0.000737	CcSEcCtD
Etodolac—Vomiting—Ifosfamide—testicular cancer	0.000226	0.000736	CcSEcCtD
Etodolac—Hypersensitivity—Cisplatin—testicular cancer	0.000226	0.000735	CcSEcCtD
Etodolac—Renal failure—Doxorubicin—testicular cancer	0.000225	0.000731	CcSEcCtD
Etodolac—Rash—Ifosfamide—testicular cancer	0.000224	0.00073	CcSEcCtD
Etodolac—Dermatitis—Ifosfamide—testicular cancer	0.000224	0.000729	CcSEcCtD
Etodolac—Erythema multiforme—Methotrexate—testicular cancer	0.000224	0.000729	CcSEcCtD
Etodolac—Urticaria—Etoposide—testicular cancer	0.000223	0.000727	CcSEcCtD
Etodolac—Haemoglobin—Epirubicin—testicular cancer	0.000223	0.000725	CcSEcCtD
Etodolac—Jaundice—Doxorubicin—testicular cancer	0.000223	0.000725	CcSEcCtD
Etodolac—Stomatitis—Doxorubicin—testicular cancer	0.000223	0.000725	CcSEcCtD
Etodolac—Rhinitis—Epirubicin—testicular cancer	0.000222	0.000723	CcSEcCtD
Etodolac—Abdominal pain—Etoposide—testicular cancer	0.000222	0.000723	CcSEcCtD
Etodolac—Body temperature increased—Etoposide—testicular cancer	0.000222	0.000723	CcSEcCtD
Etodolac—Conjunctivitis—Doxorubicin—testicular cancer	0.000222	0.000723	CcSEcCtD
Etodolac—Hepatitis—Epirubicin—testicular cancer	0.000222	0.000722	CcSEcCtD
Etodolac—Haemorrhage—Epirubicin—testicular cancer	0.000222	0.000722	CcSEcCtD
Etodolac—Tinnitus—Methotrexate—testicular cancer	0.000221	0.000719	CcSEcCtD
Etodolac—Asthenia—Cisplatin—testicular cancer	0.00022	0.000716	CcSEcCtD
Etodolac—Pharyngitis—Epirubicin—testicular cancer	0.00022	0.000716	CcSEcCtD
Etodolac—Sweating—Doxorubicin—testicular cancer	0.000219	0.000713	CcSEcCtD
Etodolac—Haematuria—Doxorubicin—testicular cancer	0.000218	0.000709	CcSEcCtD
Etodolac—Sinusitis—Doxorubicin—testicular cancer	0.000215	0.000698	CcSEcCtD
Etodolac—Visual impairment—Epirubicin—testicular cancer	0.000214	0.000695	CcSEcCtD
Etodolac—Agranulocytosis—Doxorubicin—testicular cancer	0.000213	0.000694	CcSEcCtD
Etodolac—Chills—Methotrexate—testicular cancer	0.000213	0.000692	CcSEcCtD
Etodolac—Nausea—Ifosfamide—testicular cancer	0.000211	0.000688	CcSEcCtD
Etodolac—Diarrhoea—Cisplatin—testicular cancer	0.00021	0.000683	CcSEcCtD
Etodolac—Erythema multiforme—Epirubicin—testicular cancer	0.00021	0.000682	CcSEcCtD
Etodolac—Alopecia—Methotrexate—testicular cancer	0.00021	0.000681	CcSEcCtD
Etodolac—Hypersensitivity—Etoposide—testicular cancer	0.000207	0.000674	CcSEcCtD
Etodolac—Tinnitus—Epirubicin—testicular cancer	0.000207	0.000673	CcSEcCtD
Etodolac—Haemoglobin—Doxorubicin—testicular cancer	0.000206	0.000671	CcSEcCtD
Etodolac—Flushing—Epirubicin—testicular cancer	0.000206	0.00067	CcSEcCtD
Etodolac—Rhinitis—Doxorubicin—testicular cancer	0.000206	0.000669	CcSEcCtD
Etodolac—Haemorrhage—Doxorubicin—testicular cancer	0.000205	0.000668	CcSEcCtD
Etodolac—Hepatitis—Doxorubicin—testicular cancer	0.000205	0.000668	CcSEcCtD
Etodolac—Pharyngitis—Doxorubicin—testicular cancer	0.000204	0.000663	CcSEcCtD
Etodolac—Dysgeusia—Methotrexate—testicular cancer	0.000202	0.000657	CcSEcCtD
Etodolac—Asthenia—Etoposide—testicular cancer	0.000202	0.000656	CcSEcCtD
Etodolac—Chills—Epirubicin—testicular cancer	0.000199	0.000647	CcSEcCtD
Etodolac—Pruritus—Etoposide—testicular cancer	0.000199	0.000647	CcSEcCtD
Etodolac—Arrhythmia—Epirubicin—testicular cancer	0.000198	0.000645	CcSEcCtD
Etodolac—Visual impairment—Doxorubicin—testicular cancer	0.000198	0.000643	CcSEcCtD
Etodolac—Alopecia—Epirubicin—testicular cancer	0.000196	0.000638	CcSEcCtD
Etodolac—Vomiting—Cisplatin—testicular cancer	0.000195	0.000635	CcSEcCtD
Etodolac—Vision blurred—Methotrexate—testicular cancer	0.000195	0.000633	CcSEcCtD
Etodolac—Erythema multiforme—Doxorubicin—testicular cancer	0.000194	0.000631	CcSEcCtD
Etodolac—Rash—Cisplatin—testicular cancer	0.000194	0.000629	CcSEcCtD
Etodolac—Dermatitis—Cisplatin—testicular cancer	0.000193	0.000629	CcSEcCtD
Etodolac—Diarrhoea—Etoposide—testicular cancer	0.000192	0.000626	CcSEcCtD
Etodolac—Ill-defined disorder—Methotrexate—testicular cancer	0.000191	0.000623	CcSEcCtD
Etodolac—Tinnitus—Doxorubicin—testicular cancer	0.000191	0.000622	CcSEcCtD
Etodolac—Anaemia—Methotrexate—testicular cancer	0.000191	0.00062	CcSEcCtD
Etodolac—Flushing—Doxorubicin—testicular cancer	0.000191	0.00062	CcSEcCtD
Etodolac—Flatulence—Epirubicin—testicular cancer	0.00019	0.000619	CcSEcCtD
Etodolac—Tension—Epirubicin—testicular cancer	0.00019	0.000616	CcSEcCtD
Etodolac—Dysgeusia—Epirubicin—testicular cancer	0.000189	0.000615	CcSEcCtD
Etodolac—Nervousness—Epirubicin—testicular cancer	0.000188	0.00061	CcSEcCtD
Etodolac—Malaise—Methotrexate—testicular cancer	0.000186	0.000605	CcSEcCtD
Etodolac—Dizziness—Etoposide—testicular cancer	0.000186	0.000605	CcSEcCtD
Etodolac—Vertigo—Methotrexate—testicular cancer	0.000185	0.000603	CcSEcCtD
Etodolac—Leukopenia—Methotrexate—testicular cancer	0.000185	0.000601	CcSEcCtD
Etodolac—Chills—Doxorubicin—testicular cancer	0.000184	0.000599	CcSEcCtD
Etodolac—Arrhythmia—Doxorubicin—testicular cancer	0.000183	0.000596	CcSEcCtD
Etodolac—Nausea—Cisplatin—testicular cancer	0.000182	0.000593	CcSEcCtD
Etodolac—Vision blurred—Epirubicin—testicular cancer	0.000182	0.000592	CcSEcCtD
Etodolac—Alopecia—Doxorubicin—testicular cancer	0.000181	0.00059	CcSEcCtD
Etodolac—Ill-defined disorder—Epirubicin—testicular cancer	0.000179	0.000583	CcSEcCtD
Etodolac—Convulsion—Methotrexate—testicular cancer	0.000179	0.000582	CcSEcCtD
Etodolac—Vomiting—Etoposide—testicular cancer	0.000179	0.000581	CcSEcCtD
Etodolac—Anaemia—Epirubicin—testicular cancer	0.000179	0.000581	CcSEcCtD
Etodolac—Rash—Etoposide—testicular cancer	0.000177	0.000577	CcSEcCtD
Etodolac—Dermatitis—Etoposide—testicular cancer	0.000177	0.000576	CcSEcCtD
Etodolac—Headache—Etoposide—testicular cancer	0.000176	0.000573	CcSEcCtD
Etodolac—Flatulence—Doxorubicin—testicular cancer	0.000176	0.000573	CcSEcCtD
Etodolac—Myalgia—Methotrexate—testicular cancer	0.000176	0.000571	CcSEcCtD
Etodolac—Arthralgia—Methotrexate—testicular cancer	0.000176	0.000571	CcSEcCtD
Etodolac—Tension—Doxorubicin—testicular cancer	0.000175	0.00057	CcSEcCtD
Etodolac—Dysgeusia—Doxorubicin—testicular cancer	0.000175	0.000569	CcSEcCtD
Etodolac—Malaise—Epirubicin—testicular cancer	0.000174	0.000566	CcSEcCtD
Etodolac—Discomfort—Methotrexate—testicular cancer	0.000174	0.000565	CcSEcCtD
Etodolac—Nervousness—Doxorubicin—testicular cancer	0.000174	0.000564	CcSEcCtD
Etodolac—Vertigo—Epirubicin—testicular cancer	0.000174	0.000564	CcSEcCtD
Etodolac—Syncope—Epirubicin—testicular cancer	0.000173	0.000563	CcSEcCtD
Etodolac—Leukopenia—Epirubicin—testicular cancer	0.000173	0.000562	CcSEcCtD
Etodolac—Palpitations—Epirubicin—testicular cancer	0.000171	0.000555	CcSEcCtD
Etodolac—Confusional state—Methotrexate—testicular cancer	0.00017	0.000552	CcSEcCtD
Etodolac—Loss of consciousness—Epirubicin—testicular cancer	0.00017	0.000552	CcSEcCtD
Etodolac—Anaphylactic shock—Methotrexate—testicular cancer	0.000168	0.000548	CcSEcCtD
Etodolac—Vision blurred—Doxorubicin—testicular cancer	0.000168	0.000548	CcSEcCtD
Etodolac—Convulsion—Epirubicin—testicular cancer	0.000167	0.000544	CcSEcCtD
Etodolac—Infection—Methotrexate—testicular cancer	0.000167	0.000544	CcSEcCtD
Etodolac—Nausea—Etoposide—testicular cancer	0.000167	0.000543	CcSEcCtD
Etodolac—Hypertension—Epirubicin—testicular cancer	0.000167	0.000542	CcSEcCtD
Etodolac—Ill-defined disorder—Doxorubicin—testicular cancer	0.000166	0.000539	CcSEcCtD
Etodolac—Anaemia—Doxorubicin—testicular cancer	0.000165	0.000537	CcSEcCtD
Etodolac—Thrombocytopenia—Methotrexate—testicular cancer	0.000165	0.000536	CcSEcCtD
Etodolac—Arthralgia—Epirubicin—testicular cancer	0.000164	0.000535	CcSEcCtD
Etodolac—Myalgia—Epirubicin—testicular cancer	0.000164	0.000535	CcSEcCtD
Etodolac—Anxiety—Epirubicin—testicular cancer	0.000164	0.000533	CcSEcCtD
Etodolac—Hyperhidrosis—Methotrexate—testicular cancer	0.000163	0.00053	CcSEcCtD
Etodolac—Discomfort—Epirubicin—testicular cancer	0.000162	0.000528	CcSEcCtD
Etodolac—Malaise—Doxorubicin—testicular cancer	0.000161	0.000524	CcSEcCtD
Etodolac—Dry mouth—Epirubicin—testicular cancer	0.000161	0.000523	CcSEcCtD
Etodolac—Vertigo—Doxorubicin—testicular cancer	0.000161	0.000522	CcSEcCtD
Etodolac—Anorexia—Methotrexate—testicular cancer	0.000161	0.000522	CcSEcCtD
Etodolac—Syncope—Doxorubicin—testicular cancer	0.00016	0.000521	CcSEcCtD
Etodolac—Leukopenia—Doxorubicin—testicular cancer	0.00016	0.00052	CcSEcCtD
Etodolac—Confusional state—Epirubicin—testicular cancer	0.000159	0.000517	CcSEcCtD
Etodolac—Palpitations—Doxorubicin—testicular cancer	0.000158	0.000514	CcSEcCtD
Etodolac—Oedema—Epirubicin—testicular cancer	0.000158	0.000513	CcSEcCtD
Etodolac—Anaphylactic shock—Epirubicin—testicular cancer	0.000158	0.000513	CcSEcCtD
Etodolac—Hypotension—Methotrexate—testicular cancer	0.000157	0.000512	CcSEcCtD
Etodolac—Loss of consciousness—Doxorubicin—testicular cancer	0.000157	0.000511	CcSEcCtD
Etodolac—Infection—Epirubicin—testicular cancer	0.000157	0.000509	CcSEcCtD
Etodolac—Shock—Epirubicin—testicular cancer	0.000155	0.000504	CcSEcCtD
Etodolac—Convulsion—Doxorubicin—testicular cancer	0.000155	0.000504	CcSEcCtD
Etodolac—Thrombocytopenia—Epirubicin—testicular cancer	0.000154	0.000502	CcSEcCtD
Etodolac—Hypertension—Doxorubicin—testicular cancer	0.000154	0.000502	CcSEcCtD
Etodolac—Tachycardia—Epirubicin—testicular cancer	0.000154	0.0005	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000153	0.000499	CcSEcCtD
Etodolac—Hyperhidrosis—Epirubicin—testicular cancer	0.000152	0.000496	CcSEcCtD
Etodolac—Insomnia—Methotrexate—testicular cancer	0.000152	0.000495	CcSEcCtD
Etodolac—Arthralgia—Doxorubicin—testicular cancer	0.000152	0.000495	CcSEcCtD
Etodolac—Myalgia—Doxorubicin—testicular cancer	0.000152	0.000495	CcSEcCtD
Etodolac—Anxiety—Doxorubicin—testicular cancer	0.000152	0.000493	CcSEcCtD
Etodolac—Paraesthesia—Methotrexate—testicular cancer	0.000151	0.000492	CcSEcCtD
Etodolac—Discomfort—Doxorubicin—testicular cancer	0.00015	0.000489	CcSEcCtD
Etodolac—Anorexia—Epirubicin—testicular cancer	0.00015	0.000489	CcSEcCtD
Etodolac—Dyspnoea—Methotrexate—testicular cancer	0.00015	0.000488	CcSEcCtD
Etodolac—Somnolence—Methotrexate—testicular cancer	0.00015	0.000487	CcSEcCtD
Etodolac—Dry mouth—Doxorubicin—testicular cancer	0.000149	0.000484	CcSEcCtD
Etodolac—Dyspepsia—Methotrexate—testicular cancer	0.000148	0.000482	CcSEcCtD
Etodolac—Hypotension—Epirubicin—testicular cancer	0.000147	0.000479	CcSEcCtD
Etodolac—Confusional state—Doxorubicin—testicular cancer	0.000147	0.000478	CcSEcCtD
Etodolac—Decreased appetite—Methotrexate—testicular cancer	0.000146	0.000476	CcSEcCtD
Etodolac—Oedema—Doxorubicin—testicular cancer	0.000146	0.000474	CcSEcCtD
Etodolac—Anaphylactic shock—Doxorubicin—testicular cancer	0.000146	0.000474	CcSEcCtD
Etodolac—Fatigue—Methotrexate—testicular cancer	0.000145	0.000472	CcSEcCtD
Etodolac—Infection—Doxorubicin—testicular cancer	0.000145	0.000471	CcSEcCtD
Etodolac—Pain—Methotrexate—testicular cancer	0.000144	0.000468	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000144	0.000467	CcSEcCtD
Etodolac—Shock—Doxorubicin—testicular cancer	0.000143	0.000467	CcSEcCtD
Etodolac—Thrombocytopenia—Doxorubicin—testicular cancer	0.000143	0.000464	CcSEcCtD
Etodolac—Insomnia—Epirubicin—testicular cancer	0.000143	0.000464	CcSEcCtD
Etodolac—Tachycardia—Doxorubicin—testicular cancer	0.000142	0.000463	CcSEcCtD
Etodolac—Paraesthesia—Epirubicin—testicular cancer	0.000142	0.00046	CcSEcCtD
Etodolac—Hyperhidrosis—Doxorubicin—testicular cancer	0.000141	0.000459	CcSEcCtD
Etodolac—Dyspnoea—Epirubicin—testicular cancer	0.000141	0.000457	CcSEcCtD
Etodolac—Somnolence—Epirubicin—testicular cancer	0.00014	0.000456	CcSEcCtD
Etodolac—Anorexia—Doxorubicin—testicular cancer	0.000139	0.000452	CcSEcCtD
Etodolac—Feeling abnormal—Methotrexate—testicular cancer	0.000139	0.000451	CcSEcCtD
Etodolac—Dyspepsia—Epirubicin—testicular cancer	0.000139	0.000451	CcSEcCtD
Etodolac—Gastrointestinal pain—Methotrexate—testicular cancer	0.000138	0.000448	CcSEcCtD
Etodolac—Decreased appetite—Epirubicin—testicular cancer	0.000137	0.000446	CcSEcCtD
Etodolac—Hypotension—Doxorubicin—testicular cancer	0.000136	0.000443	CcSEcCtD
Etodolac—Fatigue—Epirubicin—testicular cancer	0.000136	0.000442	CcSEcCtD
Etodolac—Constipation—Epirubicin—testicular cancer	0.000135	0.000438	CcSEcCtD
Etodolac—Pain—Epirubicin—testicular cancer	0.000135	0.000438	CcSEcCtD
Etodolac—Urticaria—Methotrexate—testicular cancer	0.000134	0.000435	CcSEcCtD
Etodolac—Body temperature increased—Methotrexate—testicular cancer	0.000133	0.000433	CcSEcCtD
Etodolac—Abdominal pain—Methotrexate—testicular cancer	0.000133	0.000433	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000133	0.000432	CcSEcCtD
Etodolac—Insomnia—Doxorubicin—testicular cancer	0.000132	0.000429	CcSEcCtD
Etodolac—Paraesthesia—Doxorubicin—testicular cancer	0.000131	0.000426	CcSEcCtD
Etodolac—Dyspnoea—Doxorubicin—testicular cancer	0.00013	0.000423	CcSEcCtD
Etodolac—Feeling abnormal—Epirubicin—testicular cancer	0.00013	0.000422	CcSEcCtD
Etodolac—Somnolence—Doxorubicin—testicular cancer	0.00013	0.000422	CcSEcCtD
Etodolac—Gastrointestinal pain—Epirubicin—testicular cancer	0.000129	0.000419	CcSEcCtD
Etodolac—Dyspepsia—Doxorubicin—testicular cancer	0.000128	0.000418	CcSEcCtD
Etodolac—Decreased appetite—Doxorubicin—testicular cancer	0.000127	0.000412	CcSEcCtD
Etodolac—Fatigue—Doxorubicin—testicular cancer	0.000126	0.000409	CcSEcCtD
Etodolac—Urticaria—Epirubicin—testicular cancer	0.000125	0.000407	CcSEcCtD
Etodolac—Pain—Doxorubicin—testicular cancer	0.000125	0.000406	CcSEcCtD
Etodolac—Constipation—Doxorubicin—testicular cancer	0.000125	0.000406	CcSEcCtD
Etodolac—Body temperature increased—Epirubicin—testicular cancer	0.000125	0.000405	CcSEcCtD
Etodolac—Abdominal pain—Epirubicin—testicular cancer	0.000125	0.000405	CcSEcCtD
Etodolac—Hypersensitivity—Methotrexate—testicular cancer	0.000124	0.000404	CcSEcCtD
Etodolac—Asthenia—Methotrexate—testicular cancer	0.000121	0.000393	CcSEcCtD
Etodolac—Feeling abnormal—Doxorubicin—testicular cancer	0.00012	0.000391	CcSEcCtD
Etodolac—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000119	0.000388	CcSEcCtD
Etodolac—Pruritus—Methotrexate—testicular cancer	0.000119	0.000388	CcSEcCtD
Etodolac—Hypersensitivity—Epirubicin—testicular cancer	0.000116	0.000378	CcSEcCtD
Etodolac—Urticaria—Doxorubicin—testicular cancer	0.000116	0.000377	CcSEcCtD
Etodolac—Abdominal pain—Doxorubicin—testicular cancer	0.000115	0.000375	CcSEcCtD
Etodolac—Body temperature increased—Doxorubicin—testicular cancer	0.000115	0.000375	CcSEcCtD
Etodolac—Diarrhoea—Methotrexate—testicular cancer	0.000115	0.000375	CcSEcCtD
Etodolac—Asthenia—Epirubicin—testicular cancer	0.000113	0.000368	CcSEcCtD
Etodolac—Pruritus—Epirubicin—testicular cancer	0.000112	0.000363	CcSEcCtD
Etodolac—Dizziness—Methotrexate—testicular cancer	0.000111	0.000362	CcSEcCtD
Etodolac—Diarrhoea—Epirubicin—testicular cancer	0.000108	0.000351	CcSEcCtD
Etodolac—Hypersensitivity—Doxorubicin—testicular cancer	0.000107	0.000349	CcSEcCtD
Etodolac—Vomiting—Methotrexate—testicular cancer	0.000107	0.000348	CcSEcCtD
Etodolac—Rash—Methotrexate—testicular cancer	0.000106	0.000345	CcSEcCtD
Etodolac—Dermatitis—Methotrexate—testicular cancer	0.000106	0.000345	CcSEcCtD
Etodolac—Headache—Methotrexate—testicular cancer	0.000106	0.000343	CcSEcCtD
Etodolac—Asthenia—Doxorubicin—testicular cancer	0.000105	0.00034	CcSEcCtD
Etodolac—Dizziness—Epirubicin—testicular cancer	0.000104	0.000339	CcSEcCtD
Etodolac—Pruritus—Doxorubicin—testicular cancer	0.000103	0.000336	CcSEcCtD
Etodolac—Vomiting—Epirubicin—testicular cancer	0.0001	0.000326	CcSEcCtD
Etodolac—Nausea—Methotrexate—testicular cancer	0.0001	0.000325	CcSEcCtD
Etodolac—Diarrhoea—Doxorubicin—testicular cancer	9.98e-05	0.000325	CcSEcCtD
Etodolac—Rash—Epirubicin—testicular cancer	9.94e-05	0.000323	CcSEcCtD
Etodolac—Dermatitis—Epirubicin—testicular cancer	9.93e-05	0.000323	CcSEcCtD
Etodolac—Headache—Epirubicin—testicular cancer	9.88e-05	0.000321	CcSEcCtD
Etodolac—Dizziness—Doxorubicin—testicular cancer	9.65e-05	0.000314	CcSEcCtD
Etodolac—Nausea—Epirubicin—testicular cancer	9.36e-05	0.000304	CcSEcCtD
Etodolac—Vomiting—Doxorubicin—testicular cancer	9.27e-05	0.000302	CcSEcCtD
Etodolac—Rash—Doxorubicin—testicular cancer	9.2e-05	0.000299	CcSEcCtD
Etodolac—Dermatitis—Doxorubicin—testicular cancer	9.19e-05	0.000299	CcSEcCtD
Etodolac—Headache—Doxorubicin—testicular cancer	9.14e-05	0.000297	CcSEcCtD
Etodolac—Nausea—Doxorubicin—testicular cancer	8.66e-05	0.000282	CcSEcCtD
